Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-22
2008-03-18
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S184000, C546S192000, C546S245000, C546S090000, C564S123000, C514S183000, C514S506000, C514S675000, C514S759000, C544S056000, C544S256000
Reexamination Certificate
active
07345174
ABSTRACT:
The present invention provides the compound having the formula:wherein each of R1and R2is, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, —O—, —S—, —NH—, or —CH2—; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.
REFERENCES:
patent: 2279560 (1942-04-01), Dietrich
patent: 2346665 (1944-04-01), Cupery
patent: 2895991 (1959-07-01), Randall et al.
patent: 3450673 (1969-06-01), McKillip
patent: 3632783 (1972-01-01), Stonis
patent: 3875301 (1975-04-01), Windheuser
patent: 4056524 (1977-11-01), Walker
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4480125 (1984-10-01), Haas et al.
patent: 4537781 (1985-08-01), Darling
patent: 4611053 (1986-09-01), Sasa
patent: 4614815 (1986-09-01), Cognigni et al.
patent: 4801748 (1989-01-01), Murahashi et al.
patent: 4863967 (1989-09-01), Hall et al.
patent: 4882346 (1989-11-01), Driscoll et al.
patent: 4935450 (1990-06-01), Cone, Jr.
patent: 4983636 (1991-01-01), Takeuchi et al.
patent: 5055608 (1991-10-01), Marks et al.
patent: 5175191 (1992-12-01), Marks et al.
patent: 5330744 (1994-07-01), Pontremoli et al.
patent: 5366982 (1994-11-01), Dereu et al.
patent: 5369108 (1994-11-01), Breslow et al.
patent: 5668179 (1997-09-01), Breslow et al.
patent: 5773474 (1998-06-01), Breslow et al.
patent: 5846960 (1998-12-01), Labrie
patent: 5900237 (1999-05-01), Napper et al.
patent: 5932616 (1999-08-01), Breslow et al.
patent: 6511990 (2003-01-01), Breslow et al.
patent: 7126001 (2006-10-01), Breslow et al.
patent: 2003/0235588 (2003-12-01), Richon et al.
patent: 2004/0018968 (2004-01-01), Sgouros et al.
patent: 2004/0087657 (2004-05-01), Richon et al.
patent: 2007/0010536 (2007-01-01), Breslow et al.
patent: 2007/0010669 (2007-01-01), Breslow et al.
patent: 26 35 558 (1977-02-01), None
patent: 0 014 230 (1980-08-01), None
patent: 0 137 640 (1985-04-01), None
patent: 0 169 645 (1986-01-01), None
patent: 0 226 304 (1987-06-01), None
patent: 0 594 577 (1998-12-01), None
patent: 1 010 705 (2000-06-01), None
patent: 1502573 (1978-03-01), None
patent: 02 219589 (1990-09-01), None
patent: WO 95/31977 (1995-11-01), None
patent: WO 99/11659 (1999-03-01), None
patent: WO 01/18171 (2001-03-01), None
Abe, E., et al., Proc. Natl. Acad. Sci. (USA), 78: 4990-4994 (1981).
Andreeff, M., et al., Blood 72: 186a, Abstract 656 (1988).
Andruszkiewicz et al., Polish Journal of Chemistry, 52: 2147-2156 (1978).
Blazejewski, J.C., et al., Tet. Letters, 40: 5475-5478 (1999).
Boivin, J.; et al., Tet. Lett. 33: 1285-1288 (1992).
Breitman, T. R., et al., Proc. Natl. Acad. Sci. USA, 77: 2936-2940 (1980).
Brown, D., et al., 23-Aliphatics, 105: 605 (1986) (from Synth. Commun., 1985, 15: 1159-1164, Abstract No. 78501v).
Brown, D.A., et al., Inorganic Chemistry, 25: 3792-3796 (1986).
Burden, R.S., et al., J. Chem. Soc. (C) 2477 (1969).
Butler, L.M. et al., Cancer Res. 60:5165-5170 (2000).
Callery, P.S., et al., Cancer Res., 46: 4900-4903 (1986).
Cehnevert, R., et al., Can. J. Chem., 72: 2212-2317 (1994).
Chun, H.G., et al., Cancer Treatment Reports, 70: 991-996 (1986).
Cohen, L.A. et al., Anticancer Research 19:4999-5006 (1999).
D. W. Christianson, et al., J. Am. Chem. Soc., 108: 4998-5003 1986.
Das, M.K., et al., Chemical Abstracts, 101: 582 (1984) (from J. Chem. Eng. Data, 1984, 29: 345-348, Abstract No. 546651).
Database Beilstein, Registry No. 1799161; Beilstein Institute for Organic Chemistry, Frankfurt; Johnson, J. Chem. Soc., 1946, 1013 (1989).
Database HCAPLUS, ACS, Accession No. 1991:99992; Kazuhisa, (1991).
Desai et al., Proc. AACR 40: Abstract No. 2396 (1999).
Durrant, G.; et al., J. Chem. Soc., Perkin Trans. I, 2211-2214 (1983).
Ebert, P. S., et al. Cancer Res., 36: 1809-1813 (1976).
Egorin, M.J., et al., Cancer Research, 47: 617-623 (1987).
Farquhar, D., et al., J. Med. Chem., 41: 965-972 (1998).
Fibach, E., et al., Cancer Research, 37: 440-444 (1977).
Finnin, M.S., et al., Nature 401:188-193 (1999).
Friend, C., et al., Proc. Natl. Acad. Sci. (USA), 68:378-382 (1971).
Haces, A., et al., J. Med. Chem., 30: 405-409 (1987).
Hayashi, M., et al., Gann, 70: 235-238 (1979).
Hozumi, T., et al., Chemical Abstracts, 90 (13) (from Int. J. Cancer, 23: 119-122, 1979), Abstract No. 1162482.
Hozumi, T., et al., Int. J. Cancer, 23: 119-122 (1979).
Huberman, E. et al., Proc. Natl. Acad. Sci. (USA), 76: 1293-1297 (1979).
Hynes, J.B., Jour. of Medicinal Chem., 13: 1235-1237 (1970).
Iwata, S., et al., Chemical Abstracts, 125: 28 (from Jpn. Kokai Tokkyo Koho JP 08, 176,264 [96, 176,264], 1996, Abstract No. 222822h).
Jacobsen, N.E., et al., J. Am. Chem. Soc., 303: 654-657 (1981).
Jung, et al., Bioorganic & Medicinal Chemistry Letters, Oxford, 7: 1655-1658 (1997).
Kijima et al., J Biol. Chem. 268,22429-22435 (1993).
Kim et al., Oncogene, 18: 2461-2470 (1999).
Kwon et al., Proc. Natl. Acad. Sci. USA 95: 3356-3361 (1998).
Lea, et al., Int. J. Oncol., 2: 347-352 (1999).
Lea, M.A., et al., Anticancer Research, 15, 879-883 (1995).
Linderman, R.J., et al., J. Org. Chem.54: 661-668 (1989).
Lindskog, S. et al., The Enzymes, 3rd edition, P.D. Boyer, ed., 1971, V:. 587-665, (see 657) (1971).
Linfield, W.M., et al., J. Med. Chem., 26: 1741-1746 (1983).
Lotem, J. et al., Proc. Natl. Acad. Sci. (USA), 76: 5158-5162) (1979).
Lotem, J., et al., Int. J. Cancer, 15: 731-740 (1975).
Marks et al., Cancer Res., 47:659-666 (1987).
Marks, P.A., et al., Antibiotics Chemother., 23: 33-41 (1978).
Marks, P.A., et al., Cancer, 54: 2766-2769 (1984).
Marks, P.A., et al., Int. J. of Cell Cloning, 6: 230-240 (1988).
Marks, P.A., et al., Life Sciences, 322: 161-165 (1999).
Marks, P.A., et al., Proc. Natl. Acad. Sci. USA, 86: 6358-6362 (1989).
MellonI, E., et al., Proc. Natl. Acad. Sci. USA 85: 3835-3839 (1988).
Melloni, E., et al., Proc. Natl. Acad. Sciences (USA), 84: 5282-5286 (1987).
Metcalf, D., et al., Science, 229: 16-22 (1985).
Morin, M. J., et al., Cancer Res., 44: 2807-2812 (1984).
Morrison, R.T., et al., In Organic Chemistry (3rd Edition, Allyn and Bacon, Boston, Massachusetts), 755-758 (1973).
Nakajima et al., Ex. Cell Res. 241, 126-133 (1998).
Nishino, et al. Chem, Pharm. Bull., 44: 212-214 (1996).
Nishino, N., et al., Chem. Pharm. Bull., 44: 212-214 (1996).
Olsson, I. L., et al., Cancer Res., 42: 3924-3927 (1982).
Prabhakar, Y.S., et al., Arzneim.-Forsch./Drug Res., 35: 1030-1033 (1985).
Prakash, G.H.S., et al., Chem. Rev., 97: 757-786 (1997).
Reuben, R. C., et al., Proc. Natl. Acad. Sci. (USA) 73: 862-866 (1976).
Reuben, R.C., et al., Biochimica et Biophysica Acta, 605: 325-346 (1980).
Reuben, R.C., et al., J. of Biol. Chemistry, 253: 4214-4218 (1978).
Richon et al., Proc. Natl. Acad. Sci. USA, 93:5705-5708 (1996).
Richon, V. M. et al., Proc. Natl. Acad. Sci., USA, 95: 3003-3007 (1998).
Rifkind, R.A., et al., Blood Cells, 4: 189-206 (1978).
Rivard, et al., Amino Acids, 15: 389-392 (1998).
Rowinsky, E.W., et al., Cancer Res., 47: 5788-5795 (1987).
Rowinsky, E.W., et al., J. Clin. Oncol., 4: 1835-1844 (1986).
Sachs, L., Nature (Lond.), 274: 535 (1978).
Saito, A., et al., Proc. Natl. Acad. Sci. USA, 96: 4592-4597 (1999).
Scher, W. et al., Exp. Hematol., 11: 490-498 (1983).
Scher, W., et al., Biochem. & Biophys. Res. Comm., 109: 348-354) (1982).
Schwartz, E. L., et al., Cancer Res., 42: 2651-2655 (1982).
Schwartz, E. L., et al., Cancer Res., 43: 2725-2730 (1983).
Schwartz, E. L., et al., Proc. Am. Assoc. Cancer Res., 24: 18, Abstract 71 (1983).
Semonsky, et al., Collection of Czechoslovak Chemical Communications, Academic
Belvedere Sandro
Breslow Ronald
Gershell Leland
Marks Paul A.
Miller Thomas A.
Elrifi, Esq. Ivor R.
Eyler Yvonne
Mintz Levin Cohn Ferris Glovsky and Popeo PC
Sloan-Kettering Institute for Cancer Research
The Trustees of Columbia University in the City of New York
LandOfFree
Cytodifferentiating agents and histone deacetylase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytodifferentiating agents and histone deacetylase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytodifferentiating agents and histone deacetylase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965636